Showing results (231-240 of 272) with videos related to

Sort By:
Pageof 28
The New England Journal of Medicine|September 29, 2001
Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancerM R Smith, F J McGovern, A L Zietman, et al.
Cellular and Molecular Biology|September 1, 1992
EGF receptor activity and mitogenic response of Balb/3T3 cells expressing Ras and Myc oncogenes. EGF receptor activity in oncogene transformed cellsJ Gopas, M Ono, G Princler, et al.
Prostate Cancer and Prostatic Diseases|May 30, 2012
Responder analysis of the effects of denosumab on bone mineral density in men receiving androgen deprivation therapy for prostate cancerR B Egerdie, F Saad, M R Smith, et al.
Biochemical and Biophysical Research Communications|May 6, 1996
PLC gamma 1 Src homology domain induces mitogenesis in quiescent NIH 3T3 fibroblastsM R Smith, Y L Liu, S R Kim, et al.
Synapse (New York, N.Y.)|January 1, 1995
Haloperidol blocks the uptake of [18F]N-methylspiroperidol by extrastriatal dopamine receptors in schizophrenic patientsK A Yousef, N D Volkow, D J Schlyer, et al.
Archives of Environmental Contamination and Toxicology|August 15, 2001
Lead poisoning of waterfowl by contaminated sediment in the Coeur d'Alene RiverL Sileo, L H Creekmore, D J Audet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 2009
Phase II study of sunitinib in men with advanced prostate cancerM Dror Michaelson, M M Regan, W K Oh, et al.
Brazilian Journal of Biology = Revista Brasleira De Biologia|August 23, 2018
Feeding activity of the cayenne pompano Trachinotus cayennensis (Cuvier 1832) (Perciformes, Carangidae) in estuaries on the western coast of the state of Maranhão, BrazilA C L Castro, J W J Azevedo, H R S Ferreira, et al.
Cancer Research|August 1, 1995
Metabolic characterization of human non-Hodgkin's lymphomas in vivo with the use of proton-decoupled phosphorus magnetic resonance spectroscopyW G Negendank, K A Padavic-Shaller, C W Li, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 27, 2014
Denosumab for the prevention of skeletal complications in metastatic castration-resistant prostate cancer: comparison of skeletal-related events and symptomatic skeletal eventsM R Smith, R E Coleman, L Klotz, et al.
Pageof 28